Document
CVM Guidance for Industry #171 - Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated
ICR 202512-0910-001 · OMB 0910-0032 · Object 164466701.
Document Viewer [pdf]
Status: Original and derived artifacts are available for this document.
Download: pdf
Loading document viewer…
Document Metadata
| File Type | application/octet-stream |
|---|---|
| File Title | CVM Guidance for Industry #171 - Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated |
| Subject | Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated Articles Containing Active Pharma |
| Keywords | Bioequivelance, Soluble, 171, Center for Veterinary Medicine, CVM, guidance, GFI, Aqueous, Type A Medicated Articles |
| Author | FDA CVM |
| Last Modified By | Acrobat PDFMaker 23 for Word |
| File Modified | 2025-12-01 |
| File Created | 2023-06-08 |
| Conversion State | complete |